Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Farmers Insurance
Argus Health
US Department of Justice

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090656

« Back to Dashboard

NDA 090656 describes TORSEMIDE, which is a drug marketed by Luitpold, West-ward Pharms Int, Apotex Inc, Aurobindo Pharma, Hetero Labs Ltd Iii, Par Pharm, Pliva Pharm Ind, Sun Pharm Inds, Teva, and Vintage Pharms, and is included in eleven NDAs. It is available from seventeen suppliers. Additional details are available on the TORSEMIDE profile page.

The generic ingredient in TORSEMIDE is torsemide. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the torsemide profile page.

Summary for 090656

Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 090656

Suppliers and Packaging for NDA: 090656

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TORSEMIDE torsemide INJECTABLE;INJECTION 090656 ANDA American Regent, Inc. 0517-0770 0517-0770-10 10 VIAL, SINGLE-DOSE in 1 CARTON (0517-0770-10) > 2 mL in 1 VIAL, SINGLE-DOSE (0517-0770-01)
TORSEMIDE torsemide INJECTABLE;INJECTION 090656 ANDA American Regent, Inc. 0517-0771 0517-0771-10 10 VIAL, SINGLE-DOSE in 1 CARTON (0517-0771-10) > 5 mL in 1 VIAL, SINGLE-DOSE (0517-0771-01)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength20MG/2ML (10MG/ML)
Approval Date:Apr 21, 2010TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength50MG/5ML (10MG/ML)
Approval Date:Apr 21, 2010TE:RLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: